应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DYN 戴纳基
盘前交易 11-26 07:47:20 EST
29.45
-0.24
-0.81%
盘前
29.45
+0.00
0.00%
07:33 EST
最高
30.77
最低
29.19
成交量
112.62万
今开
29.63
昨收
29.69
日振幅
5.32%
总市值
29.97亿
流通市值
21.90亿
总股本
1.02亿
成交额
3,339万
换手率
1.51%
流通股本
7,438万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
美国研究综述-Allstate、Mongodb、Primerica
路透中文 · 14:38
美国研究综述-Allstate、Mongodb、Primerica
美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛
Reuters · 11-20
美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛
戴纳基2024财年第三财季实现净利润-97.13百万美元,同比减少61.32%
市场透视 · 11-19
戴纳基2024财年第三财季实现净利润-97.13百万美元,同比减少61.32%
戴纳基盘中异动 早盘股价大涨5.52%报30.95美元
市场透视 · 11-13
戴纳基盘中异动 早盘股价大涨5.52%报30.95美元
戴纳基盘中异动 大幅上涨5.62%
市场透视 · 11-12
戴纳基盘中异动 大幅上涨5.62%
戴纳基盘中异动 快速上涨5.84%报30.29美元
市场透视 · 11-06
戴纳基盘中异动 快速上涨5.84%报30.29美元
Dyne Therapeutics Inc 预计每股亏损71美分 - 财报前瞻
Reuters · 10-25
Dyne Therapeutics Inc 预计每股亏损71美分 - 财报前瞻
戴纳基盘中异动 股价大跌5.13%
市场透视 · 10-25
戴纳基盘中异动 股价大跌5.13%
BUZZ-摩根大通将 Dyne Therapeutics 的评级下调至 "中性",导致其股价下跌
Reuters · 10-24
BUZZ-摩根大通将 Dyne Therapeutics 的评级下调至 "中性",导致其股价下跌
戴纳基盘中异动 下午盘股价大跌5.05%报33.46美元
市场透视 · 10-22
戴纳基盘中异动 下午盘股价大跌5.05%报33.46美元
戴纳基盘中异动 急速拉升5.03%
市场透视 · 10-17
戴纳基盘中异动 急速拉升5.03%
戴纳基盘中异动 早盘快速上涨5.30%
市场透视 · 10-08
戴纳基盘中异动 早盘快速上涨5.30%
戴纳基盘中异动 股价大跌5.01%
市场透视 · 10-04
戴纳基盘中异动 股价大跌5.01%
戴纳基盘中异动 大幅跳水5.04%报34.11美元
市场透视 · 10-02
戴纳基盘中异动 大幅跳水5.04%报34.11美元
戴纳基盘中异动 早盘急速拉升5.08%报35.55美元
市场透视 · 09-30
戴纳基盘中异动 早盘急速拉升5.08%报35.55美元
戴纳基盘中异动 下午盘股价大涨5.21%
市场透视 · 09-26
戴纳基盘中异动 下午盘股价大涨5.21%
戴纳基盘中异动 临近收盘股价大跌5.00%
市场透视 · 09-24
戴纳基盘中异动 临近收盘股价大跌5.00%
戴纳基盘中异动 大幅拉升5.13%报36.10美元
市场透视 · 09-19
戴纳基盘中异动 大幅拉升5.13%报36.10美元
BUZZ--美国股票走势-沃尔格林、铜矿商、西蒙地产
Reuters · 09-04
BUZZ--美国股票走势-沃尔格林、铜矿商、西蒙地产
BUZZ-Dyne Therapeutics 因药物试验的安全性问题和管理层变动而暴跌
Reuters · 09-03
BUZZ-Dyne Therapeutics 因药物试验的安全性问题和管理层变动而暴跌
加载更多
公司概况
公司名称:
戴纳基
所属市场:
NASDAQ
上市日期:
--
主营业务:
Dyne Therapeutics, Inc.于2017年12月1日根据特拉华州法律注册成立。该公司正在建立一家领先的肌肉疾病公司,致力于开发针对遗传驱动疾病患者的创新性改变生命的疗法。该公司正在利用其专有的FORCE平台来克服当前肌肉组织输送的局限性,并发展用于肌肉疾病的现代寡核苷酸疗法。
发行价格:
--
{"stockData":{"symbol":"DYN","market":"US","secType":"STK","nameCN":"戴纳基","latestPrice":29.45,"timestamp":1732568400000,"preClose":29.69,"halted":0,"volume":1126214,"hourTrading":{"tag":"盘前","latestPrice":29.45,"preClose":29.45,"latestTime":"07:33 EST","volume":2113,"amount":62226.723771,"timestamp":1732624418055},"delay":0,"floatShares":74378774,"shares":101765958,"eps":-3.506673,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.24,"latestTime":"11-26 07:47:20 EST","open":29.63,"high":30.77,"low":29.19,"amount":33390493.837229997,"amplitude":0.053217,"askPrice":35.82,"askSize":100,"bidPrice":27.03,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.506673,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732631400000},"adr":0,"listingDate":1600315200000,"adjPreClose":29.45,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":29.45,"preClose":29.45,"latestTime":"07:33 EST","volume":2113,"amount":62226.723771,"timestamp":1732624418055},"postHourTrading":{"tag":"盘后","latestPrice":29.45,"preClose":29.45,"latestTime":"18:08 EST","volume":137044,"amount":4036016.7734,"timestamp":1732576082922},"volumeRatio":1.1258824533245726,"impliedVol":0.986,"impliedVolPercentile":0.8016},"requestUrl":"/m/hq/s/DYN","defaultTab":"news","newsList":[{"id":"2486704569","title":"美国研究综述-Allstate、Mongodb、Primerica","url":"https://stock-news.laohu8.com/highlight/detail?id=2486704569","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486704569?lang=zh_cn&edition=full","pubTime":"2024-11-26 14:38","pubTimestamp":1732603125,"startTime":"0","endTime":"0","summary":"美国研究综述-Allstate、Mongodb、Primerica路透社11月26日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 Allstate、Mongodb 和 Primerica。公司要闻 * 安捷伦科技公司A.N:摩根大通将其目标价从165美元下调至160美元 * Allstate Corp ALL.N:Piper Sandler将目标价从206美元上调至244美元 * Mongodb Inc MDB.O:Piper Sandler将目标价从335美元上调至425美元 * Primerica Inc PRI.N:TD Cowen将目标价从314美元上调至345美元 * UnitedHealth UNH.N:RBC 将目标价从 595 美元上调至 655 美元以下是路透社周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3S3MX0IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNH","PRI","HBBD.SI","OKE","LU2097828474.EUR","RNA","GDRX","LU0831103253.SGD","MBIN","LU0501845795.SGD","LESL","LU0823038988.USD","09988","LU0545039389.USD","LU1223082519.USD","LU2087589342.USD","NEM","ONB","CENT","SG9999014906.USD","SMTC","89988","DYN","IE000M9KFDE8.USD","LU1152091168.USD","LU0823413660.USD","BABA","ENTA","HK0000320223.HKD","LU0029874905.USD","A","LU0499858438.USD","LU0788108826.HKD","LU0918141705.HKD","LU0648948544.HKD","BBWI","LU2324357040.USD","SUM","ALEC","APGE","ALL","LU0234572021.USD","TDOC","MDB","LU2413666426.HKD","SNDR","COLM","LU0132412106.USD"],"gpt_icon":1},{"id":"2484715456","title":"美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2484715456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484715456?lang=zh_cn&edition=full","pubTime":"2024-11-20 14:56","pubTimestamp":1732085774,"startTime":"0","endTime":"0","summary":" 路透11月20日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括 Apellis Pharmaceuticals、Energizer Holdings 和沃尔玛。要闻 * Apellis Pharmaceuticals Inc :摩根大通将目标价从57美元下调至50美元 * Chord Energy Corp :加拿大皇家银行将目标价从185美元下调至180美元 * Energizer Holdings Inc :摩根大通将其评级从 \"减持 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLS","NOG","CRM","LU1267930490.SGD","ENR","VIR","ANNX","IE00B19Z8X17.USD","LH","LU0006061336.USD","BK4187","LU2286300806.USD","LU1951198990.SGD","LU1066053197.SGD","DYN","LU2430703251.USD","LU0310799852.SGD","ABUS","BK4086","NUVL","OCSL","PIII","LOW","IE00BZ1G4Q59.USD","BERY","SWTX","BRBR","CASY","LU1551013425.SGD","LU0528227936.USD","IIIV","TVTX","WMT","FSUN","VVV","CHRD","BK4505","PBF","AZEK","VERA","OLMA","LU1988902786.USD","BK4596","MNPR","AVAV","LU0265550946.USD","BK4579","BK4528","LU2756315318.SGD","BBIO"],"gpt_icon":0},{"id":"2484916587","title":"戴纳基2024财年第三财季实现净利润-97.13百万美元,同比减少61.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484916587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484916587?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010416,"startTime":"0","endTime":"0","summary":"11月19日,戴纳基公布财报,公告显示公司2024财年第三财季净利润为-97.13百万美元,同比减少61.32%;其中营业收入为0.00美元,每股基本收益为-0.96美元。从资产负债表来看,戴纳基总负债63.30百万美元,其中短期债务4.81百万美元,资产负债比为0.13,流动比率为0.18。机构评级:截至2024年11月19日,当前有10家机构对戴纳基目标价做出预测,其中目标均价为51.50美元,其中最低目标价为35.00美元,最高目标价为66.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180023abcede91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180023abcede91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN"],"gpt_icon":0},{"id":"2483838622","title":"戴纳基盘中异动 早盘股价大涨5.52%报30.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483838622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483838622?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:25","pubTimestamp":1731511508,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时25分,戴纳基股票出现异动,股价快速拉升5.52%。截至发稿,该股报30.95美元/股,成交量14.0812万股,换手率0.14%,振幅5.92%。机构评级方面,在所有10家参与评级的机构中,90%的券商给予买入建议,10%的券商给予持有建议,无券商给予卖出建议。戴纳基股票所在的生物技术行业中,整体跌幅为0.02%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113232508971a6529&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113232508971a6529&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4505","DYN","BK4588"],"gpt_icon":0},{"id":"2482283085","title":"戴纳基盘中异动 大幅上涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482283085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482283085?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:36","pubTimestamp":1731422214,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时36分,戴纳基股票出现波动,股价大幅拉升5.62%。截至发稿,该股报29.71美元/股,成交量7.7034万股,换手率0.08%,振幅5.12%。戴纳基股票所在的生物技术行业中,整体涨幅为0.19%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223654971a6019&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223654971a6019&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4505","DYN","BK4588"],"gpt_icon":0},{"id":"2481983259","title":"戴纳基盘中异动 快速上涨5.84%报30.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481983259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481983259?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903521,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分,戴纳基股票出现波动,股价快速拉升5.84%。截至发稿,该股报30.29美元/股,成交量1.2693万股,换手率0.01%,振幅0.00%。机构评级方面,在所有10家参与评级的机构中,90%的券商给予买入建议,10%的券商给予持有建议,无券商给予卖出建议。戴纳基股票所在的生物技术行业中,整体涨幅为0.91%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622320198e40da3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622320198e40da3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4588","BK4585","BK4139","DYN"],"gpt_icon":0},{"id":"2478987274","title":"Dyne Therapeutics Inc 预计每股亏损71美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2478987274","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478987274?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:13","pubTimestamp":1729862028,"startTime":"0","endTime":"0","summary":" * Dyne Therapeutics Inc 预计在10月28日公布截至2024年9月30日的业绩时,季度收入将没有变化(预计)。* * LSEG分析师对Dyne Therapeutics Inc的平均预期是每股亏损71美分。* 华尔街对 Dyne Therapeutics Inc 的 12 个月目标价中位数为 52.50 美元,高于其上一交易日 31.10 美元的收盘价。10月25日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DYN","LENZ"],"gpt_icon":0},{"id":"2478668403","title":"戴纳基盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478668403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478668403?lang=zh_cn&edition=full","pubTime":"2024-10-25 01:09","pubTimestamp":1729789773,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日01时09分,戴纳基股票出现异动,股价快速下跌5.13%。截至发稿,该股报30.70美元/股,成交量34.1692万股,换手率0.34%,振幅4.40%。机构评级方面,在所有10家参与评级的机构中,90%的券商给予买入建议,10%的券商给予持有建议,无券商给予卖出建议。戴纳基股票所在的生物技术行业中,整体涨幅为0.06%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102501093398e3e4d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102501093398e3e4d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","DYN","BK4139","BK4588"],"gpt_icon":0},{"id":"2477507647","title":"BUZZ-摩根大通将 Dyne Therapeutics 的评级下调至 \"中性\",导致其股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2477507647","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477507647?lang=zh_cn&edition=full","pubTime":"2024-10-24 18:25","pubTimestamp":1729765528,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 10月24日 - ** 药物开发商 Dyne Therapeutics 股价盘前下跌约 4%,报 31.2 美元 ** 摩根大通将其股票评级从 \"增持 \"下调至 \"中性\",将目标价从43美元下调至35美元** 券商对DYNE-101治疗一种遗传性肌肉疾病的早中期试验的额外结果是否会 \"从根本上大幅提高成功的可能性 \"或增加近期价值持怀疑态度","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","DYN"],"gpt_icon":0},{"id":"2477892185","title":"戴纳基盘中异动 下午盘股价大跌5.05%报33.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477892185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477892185?lang=zh_cn&edition=full","pubTime":"2024-10-22 02:13","pubTimestamp":1729534404,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日02时13分,戴纳基股票出现异动,股价急速下挫5.05%。截至发稿,该股报33.46美元/股,成交量25.1725万股,换手率0.25%,振幅4.37%。机构评级方面,在所有9家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中,整体跌幅为0.70%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022021325971a16d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022021325971a16d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4505","DYN","BK4588"],"gpt_icon":0},{"id":"2476564949","title":"戴纳基盘中异动 急速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476564949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476564949?lang=zh_cn&edition=full","pubTime":"2024-10-17 00:29","pubTimestamp":1729096149,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日00时29分,戴纳基股票出现波动,股价快速拉升5.03%。截至发稿,该股报35.28美元/股,成交量17.7996万股,换手率0.18%,振幅4.32%。机构评级方面,在所有9家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中,整体跌幅为0.37%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017002910971a0acf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017002910971a0acf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN","BK4585","BK4588","BK4505","BK4139"],"gpt_icon":0},{"id":"2473475650","title":"戴纳基盘中异动 早盘快速上涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473475650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473475650?lang=zh_cn&edition=full","pubTime":"2024-10-08 22:02","pubTimestamp":1728396137,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日22时02分,戴纳基股票出现波动,股价急速上涨5.30%。截至发稿,该股报33.36美元/股,成交量28.1356万股,换手率0.28%,振幅4.51%。机构评级方面,在所有10家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中,整体涨幅为0.10%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。该公司克服了肌肉组织输送和现代寡核苷酸治疗肌肉疾病的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082202189719efc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082202189719efc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN","BK4588","BK4585","BK4505","BK4139"],"gpt_icon":0},{"id":"2472625600","title":"戴纳基盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472625600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472625600?lang=zh_cn&edition=full","pubTime":"2024-10-04 03:54","pubTimestamp":1727985268,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日03时54分,戴纳基股票出现波动,股价急速跳水5.01%。截至发稿,该股报33.77美元/股,成交量69.418万股,换手率0.69%,振幅4.60%。机构评级方面,在所有10家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中,整体跌幅为1.74%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100403542898e3a77f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100403542898e3a77f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","DYN","BK4139","BK4588"],"gpt_icon":0},{"id":"2472030415","title":"戴纳基盘中异动 大幅跳水5.04%报34.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472030415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472030415?lang=zh_cn&edition=full","pubTime":"2024-10-02 00:45","pubTimestamp":1727801151,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日00时45分,戴纳基股票出现异动,股价快速下跌5.04%。截至发稿,该股报34.11美元/股,成交量40.1572万股,换手率0.40%,振幅4.54%。机构评级方面,在所有10家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中,整体跌幅为0.06%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020045519719dbf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020045519719dbf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","BK4139","DYN","BK4588"],"gpt_icon":0},{"id":"2471380412","title":"戴纳基盘中异动 早盘急速拉升5.08%报35.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471380412","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471380412?lang=zh_cn&edition=full","pubTime":"2024-09-30 23:26","pubTimestamp":1727709988,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日23时26分,戴纳基股票出现波动,股价快速上涨5.08%。截至发稿,该股报35.55美元/股,成交量35.1346万股,换手率0.35%,振幅5.68%。机构评级方面,在所有10家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中,整体跌幅为0.12%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。该公司克服了肌肉组织输送和现代寡核苷酸治疗肌肉疾病的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930232629ab672c51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930232629ab672c51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4505","DYN","BK4588"],"gpt_icon":0},{"id":"2470829399","title":"戴纳基盘中异动 下午盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470829399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470829399?lang=zh_cn&edition=full","pubTime":"2024-09-26 01:01","pubTimestamp":1727283716,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日01时01分,戴纳基股票出现异动,股价急速拉升5.21%。截至发稿,该股报35.14美元/股,成交量23.6674万股,换手率0.24%,振幅4.07%。机构评级方面,在所有10家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中,整体跌幅为0.24%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。该公司克服了肌肉组织输送和现代寡核苷酸治疗肌肉疾病的局限性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260101579719ca62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260101579719ca62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","BK4588","BK4139","DYN"],"gpt_icon":0},{"id":"2469122425","title":"戴纳基盘中异动 临近收盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469122425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469122425?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:44","pubTimestamp":1727120697,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时44分,戴纳基股票出现波动,股价快速下挫5.00%。截至发稿,该股报34.76美元/股,成交量104.936万股,换手率1.05%,振幅5.38%。机构评级方面,在所有10家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中,整体跌幅为2.64%。戴纳基公司简介:Dyne Therapeutics Inc是一家专注于为基因驱动疾病患者提供治疗的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924034458a1dbf721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924034458a1dbf721&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","DYN","BK4585","BK4505"],"gpt_icon":0},{"id":"2468508326","title":"戴纳基盘中异动 大幅拉升5.13%报36.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468508326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468508326?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:00","pubTimestamp":1726754457,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时00分,戴纳基股票出现波动,股价大幅拉升5.13%。截至发稿,该股报36.10美元/股,成交量9.2948万股,换手率0.09%,振幅2.91%。机构评级方面,在所有10家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。戴纳基股票所在的生物技术行业中,整体涨幅为0.77%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919220057a1db32ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919220057a1db32ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN","BK4505","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2464838123","title":"BUZZ--美国股票走势-沃尔格林、铜矿商、西蒙地产","url":"https://stock-news.laohu8.com/highlight/detail?id=2464838123","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464838123?lang=zh_cn&edition=full","pubTime":"2024-09-04 00:04","pubTimestamp":1725379486,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 9月3日 - 华尔街主要股指下跌超过1%,因为投资者在评估最新的工厂活动数据,本周还将公布一系列劳动力市场报告,这些报告可能会影响美联储今年放松货币政策的程度。美东时间11:48,道琼斯工业平均指数 下跌1.08%,报41,114.45 点。标普500指数 下跌1.43%,报5567.76点;纳斯达克综合指数 下跌2.39%,报17290.837点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPG","TQQQ","NWSA","X",".IXIC","SQ","WBA","RIVN","SGRP","GOOG","SNGX","DVN","CVX","MUR","IFF","LUV","PSQ","CME","NOC","SCCO","PCVX","BUZZ","BA","JAZZ","MRO","FANG","GOOGL","FCX","MTB","AQB","FDS","IMAX","MNQmain","DJX","NVCR","HGmain","MGM","DKS","MU","PSX","TCOM",".DJI","KO","DYN","AAOI","RXRX","XOM","XYL","L","COP","SOC","OKE"],"gpt_icon":1},{"id":"2464385567","title":"BUZZ-Dyne Therapeutics 因药物试验的安全性问题和管理层变动而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2464385567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464385567?lang=zh_cn&edition=full","pubTime":"2024-09-03 23:11","pubTimestamp":1725376310,"startTime":"0","endTime":"0","summary":" 9月3日 - ** 药物开发商Dyne Therapeutics的 股价暴跌~35%,跌至30.05美元的逾三个月低点** 该公司称,在早中期研究中,2名服用最高剂量试验性药物的杜氏肌营养不良症 患者出现了严重的副作用 ** Stifel 分析师说,随着更多患者接受试验治疗,可能会出现副作用,并补充说,仍在服药和参加研究的患者减轻了经纪公司对药物安全性的担忧。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4584","BK4139","BK4585","DYN","LENZ","GBIO","BK4588","BUZZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dyne-tx.com","stockEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0417},{"period":"3month","weight":-0.3311},{"period":"6month","weight":-0.0524},{"period":"1year","weight":1.6652},{"period":"ytd","weight":1.2143}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Dyne Therapeutics, Inc.于2017年12月1日根据特拉华州法律注册成立。该公司正在建立一家领先的肌肉疾病公司,致力于开发针对遗传驱动疾病患者的创新性改变生命的疗法。该公司正在利用其专有的FORCE平台来克服当前肌肉组织输送的局限性,并发展用于肌肉疾病的现代寡核苷酸疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.103315},{"month":2,"riseRate":0.5,"avgChangeRate":0.062424},{"month":3,"riseRate":0.5,"avgChangeRate":-0.021131},{"month":4,"riseRate":0.25,"avgChangeRate":-0.02854},{"month":5,"riseRate":0.5,"avgChangeRate":0.022774},{"month":6,"riseRate":0.75,"avgChangeRate":0.124906},{"month":7,"riseRate":0.75,"avgChangeRate":0.17109},{"month":8,"riseRate":0.25,"avgChangeRate":-0.029699},{"month":9,"riseRate":0.25,"avgChangeRate":-0.044882},{"month":10,"riseRate":0.2,"avgChangeRate":-0.118868},{"month":11,"riseRate":0.6,"avgChangeRate":0.114514},{"month":12,"riseRate":0.5,"avgChangeRate":0.01734}],"exchange":"NASDAQ","name":"戴纳基","nameEN":"Dyne Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"戴纳基(DYN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供戴纳基(DYN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"戴纳基,DYN,戴纳基股票,戴纳基股票老虎,戴纳基股票老虎国际,戴纳基行情,戴纳基股票行情,戴纳基股价,戴纳基股市,戴纳基股票价格,戴纳基股票交易,戴纳基股票购买,戴纳基股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"戴纳基(DYN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供戴纳基(DYN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}